Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › LEMD3 antagonizes TGF-beta-driven Smad2/3 transcription in a stiffness-dependent fashion in both the nucleus and cytosol

LEMD3 antagonizes TGF-beta-driven Smad2/3 transcription in a stiffness-dependent fashion in both the nucleus and cytosol

US Patent 11541101 · Granted Jan 3, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for detecting and regulating fibronectin-integrin inter2025
Compositions and methods for detecting and regulating fibronectin-integrin inter2025
Functionalized microgels with fibrin binding elements2022
Functionalized microgels with fibrin binding elements2019
Peptides for binding fibrinogen and fibrin2013